Latest Beyaz Stories
Cases involving blood-clotting allegations continue to progress in United States and Canada as Resource4thePeople attorneys offer free legal consultations to U.S. consumers.
Resource4thePeople attorneys offer free legal consultations to U.S.
Bayer's annual report details progress of consolidated federal court litigation involving claims that the use of the popular contraceptives allegedly caused life-threatening side effects.
Consumer inquiries increase with news* that Bayer AG set aside over $1.5 billion to cover litigation expenses over claims that Yasmin and Yaz oral contraceptives allegedly caused blood clot risks.
Attorneys offer free consultations to victims of possible blood-clotting risks detailed by FDA review of information. San Diego CA (PRWEB) February 08, 2013
Blau, Brown & Leonard, LLC announce that they have lawyers standing by Toll Free 1-(800) YAZ-0287 if They Took Yaz, Yasmin, BeYaz or Ocella and Suffered Pulmonary Embolisms, DVT's or Stroke;
Women Injured by YAZ, YASMIN, OCELLA or BEYAZ May be Eligible to Participate in the YAZ Settlement Blau, Brown & Leonard, LLC, pioneers in birth control
WAYNE, N.J., Sept. 24 /PRNewswire/ -- Bayer HealthCare Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved a new oral contraceptive (OC), Beyaz((TM)) (drospirenone / ethinyl estradiol / levomefolate calcium tablets and levomefolate calcium tablets).